Best Device Closure of ASD (Amplatzer Septal Occluder) Treatment Hospitals Worldwide

At Aster Medcity, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2013, this NABH, JCI accredited hospital in Kochi, India has 670 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

Aakash Healthcare Super Speciality Hospital provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 2011, the NABH, ISO accredited hospital is located in Delhi, India and operates 230 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.

Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.

Thumbay University Hospital, Ajman is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2002, the JCI- accredited hospital is situated in Ajman, United Arab Emirates and has 350 beds.

Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.

Choosing Medical Park Karadeniz Hospital for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 2007, the JCI accredited hospital in Trabzon, Turkey has 112 beds and provides specialized congenital heart disease services.

Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.

At Meliva Kardiolita Hospital, Kaunas, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 1998, this JCI accredited hospital in Kaunas, Lithuania has 8 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

Choosing Bukit Tinggi Medical Centre for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 2016, the MSQH accredited hospital in Kuala Lumpur, Malaysia has 171 beds and provides specialized congenital heart disease services.

Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.

Rajagiri Hospital is a trusted healthcare provider for Device Closure of ASD (Amplatzer Septal Occluder), offering minimally invasive ASD closure supported by experienced interventional cardiologists, congenital heart specialists, advanced catheterization laboratories, and multidisciplinary cardiac care. Established in 2014, the JCI- accredited hospital is situated in Kochi, India and it has adequate bed capacity.

Device Closure of ASD (Amplatzer Septal Occluder) works by placing a self-expanding occlusion device across the atrial septal defect to block the abnormal communication between the atria. The device consists of two discs connected by a central waist that conforms to the defect. Over time, heart tissue grows over the device, helping to establish permanent closure. A detailed cardiac assessment helps determine whether the defect is anatomically suitable for device closure rather than surgical repair.

Fortis Hospital, Shalimar Bagh provides specialised Device Closure of ASD (Amplatzer Septal Occluder) with a focus on precise defect assessment, advanced transcatheter closure techniques, and individualized congenital cardiac care. Established in 2010, the NABH accredited hospital is located in Delhi, India and operates 262 beds, with modern interventional cardiology, cardiac imaging, and critical-care infrastructure.

Device Closure of ASD (Amplatzer Septal Occluder) can provide a minimally invasive alternative to open-heart surgery for selected patients with suitable secundum ASDs. Treatment planning considers the defect's size and location, surrounding tissue margins, pulmonary pressures, associated cardiac abnormalities, and the patient's overall health. Detailed echocardiographic assessment, including transesophageal or intracardiac imaging when required, helps the cardiac team select the appropriate device size and determine whether transcatheter closure is a suitable treatment option.

Choosing Max Super Specialty Hospital, Shalimar Bagh for Device Closure of ASD (Amplatzer Septal Occluder) gives patients access to experienced interventional cardiologists, advanced echocardiography and imaging systems, modern catheterization facilities, and structured post-procedure cardiac care. Established in 2011, the NABH, NABL accredited hospital in Delhi, India has 402 beds and provides specialized congenital heart disease services.

Device Closure of ASD (Amplatzer Septal Occluder) is typically performed under sedation or general anaesthesia depending on the patient's age and clinical requirements. The catheter carrying the occluder is guided through the vascular system into the heart, where the device is deployed across the ASD after confirming its position and stability. Patients are monitored after the procedure for heart rhythm changes, bleeding at the catheter site, device-related complications, or residual blood flow through the defect. Follow-up echocardiography is used to assess device position and closure.

At Amrita Hospital, Device Closure of ASD (Amplatzer Septal Occluder) is performed using specialized catheter-based cardiac techniques and comprehensive pre-procedure assessment. Established in 2022, this NABH accredited hospital in Faridabad, India has 2600 beds and offers advanced interventional and congenital cardiology services.

Device Closure of ASD (Amplatzer Septal Occluder) may be considered for patients with a suitable atrial septal defect where closure is clinically indicated. A catheter is introduced through a blood vessel, usually in the groin, and guided toward the heart. The Amplatzer device is then advanced through the catheter and carefully positioned across the ASD under imaging guidance. Echocardiography and cardiac imaging are used to assess the size, location, and surrounding structures of the defect before and during the procedure.

Marengo Asia Hospitals, Faridabad offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 2007, the NABH, NABL accredited hospital is located in Faridabad, India and has 325 beds, providing comprehensive cardiac care for local and international patients.

Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.

Marengo Asia Hospitals, Gurugram offers advanced Device Closure of ASD (Amplatzer Septal Occluder) using modern interventional cardiology techniques and individualized congenital heart disease care plans. Established in 2022, the NABH, NABL accredited hospital is located in Gurgaon, India and has 250 beds, providing comprehensive cardiac care for local and international patients.

Device Closure of ASD (Amplatzer Septal Occluder) is a minimally invasive procedure used to close a suitable atrial septal defect (ASD), an opening between the upper chambers of the heart. During the procedure, an Amplatzer Septal Occluder is delivered through a catheter and positioned across the defect. Once deployed, the device spans both sides of the opening and helps prevent abnormal blood flow between the atria. The procedure is generally considered for appropriately selected secundum ASDs with suitable anatomy.